MEDVi Review 2026: Clinician-Led GLP-1 Weight Loss, Assessed
MEDVi puts clinician supervision front and center, promising doctor-led GLP-1 weight loss rather than a hands-off script mill. That medical framing shapes the whole experience.
We looked at the depth of oversight, the medication options and the overall value to see whether MEDVi’s clinician-led promise holds up in practice.
- Type: Clinician-led GLP-1 telehealth
- Medication: Compounded semaglutide & tirzepatide
- Pricing: Membership + medication
- Availability: Most US states
- Best for: People wanting doctor-supervised care
Doctor-supervised from the start
MEDVi emphasizes real clinician involvement through onboarding, dosing and follow-up, so you’re not left to figure out escalation on your own.
That supervision is reassuring for anyone nervous about starting a GLP-1, since a provider is actively guiding the plan.
Medication and program structure
MEDVi offers compounded semaglutide and tirzepatide with provider oversight and a structured path through the program.
- Compounded semaglutide and tirzepatide
- Active clinician supervision
- Guided dose escalation
- Structured follow-up
Value assessment
MEDVi’s membership-plus-medication pricing is mid-market — not the cheapest, not premium. The clinical oversight is the main thing you’re paying for, and for people who want that reassurance, the value stacks up well.
The verdict
In short: MEDVi is a solid, clinician-led GLP-1 service that suits people who want genuine doctor supervision at a reasonable price.
Buy it if
- You want real clinician supervision
- You value guided dose escalation
- You want a structured program
Skip it if
- You want the rock-bottom cheapest option
- You prefer minimal clinical involvement
- You want branded medication only
Pros and cons
What we liked
- Strong clinician supervision
- Both semaglutide and tirzepatide
- Guided, structured dosing
- Reasonable mid-market pricing
- Reassuring for first-timers
What could be better
- Not the cheapest option
- Compounded, not FDA-approved brand-name
- Membership adds to cost
Safety and considerations
GLP-1 medications can cause nausea and other digestive effects and carry rarer serious risks; compounded versions aren’t FDA-approved like brand-name drugs. Use MEDVi under its clinicians’ supervision, share your full history, and treat this review as information, not medical advice.
Bottom line
MEDVi delivers on its clinician-led promise, pairing compounded GLP-1 medication with genuine doctor supervision at fair pricing. If active medical oversight is your priority, it’s a dependable, reassuring choice.
Frequently asked questions
What is MEDVi?
A clinician-led telehealth service offering doctor-supervised GLP-1 weight loss with compounded semaglutide and tirzepatide.
Is MEDVi doctor-supervised?
Yes — real clinician involvement through onboarding, dosing and follow-up is its central selling point.
Does MEDVi offer tirzepatide?
Yes, it offers both compounded semaglutide and tirzepatide, matched to your clinical assessment.
How much does MEDVi cost?
It uses a membership-plus-medication model at mid-market pricing — not the cheapest, not premium.
Is MEDVi good for beginners?
Yes — its active supervision and guided dosing make it reassuring for people new to GLP-1 medication.
Affiliate & medical disclosure: This review is independent and for information only, not medical advice. Some links may be affiliate links; we may earn a commission at no cost to you, which never affects our score. Consult a licensed provider before starting any product.